公开(公告)号：US20250135006A1

公开(公告)日：2025-05-01

申请号：US18763016

申请日：2024-07-03

Applicant: Pfizer Inc.

Inventor： Derek William Bartlett ,  Zoltan Beck ,  Andrew Fensome ,  Mark Edward Flanagan ,  Michael William Pride

IPC: A61K47/22 ,  A61K31/496 ,  A61K39/39 ,  A61K47/28

Abstract: The invention relates to compounds of Formula (I) and pharmaceutically acceptable salts thereof, wherein A, L, X, Y and p are as defined in the description; to their use in medicine; to compositions containing them; to processes for their preparation; and to intermediates used in such processes. The compounds of Formula (I) may modulate the activity of antigens of interest and may be useful in inducing or enhancing an immune response against diseases, disorders and conditions mediated by antigens of interest.